Immediate Impact
39 standout
Citing Papers
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Chow Wei Too being referenced
A phase II open-label, single-center, nonrandomized trial of Y90-radioembolization in combination with nivolumab in Asian patients with advanced hepatocellular carcinoma: CA 209-678.
2020
Pilot study evaluating catheter-directed contrast-enhanced ultrasound compared to catheter-directed computed tomography arteriography as adjuncts to digital subtraction angiography to guide transarterial chemoembolization
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chow Wei Too | 260 | 239 | 150 | 47 | 584 | |
| Apoorva Gogna | 279 | 394 | 124 | 70 | 703 | |
| Sam Stuart | 258 | 144 | 244 | 28 | 587 | |
| Johan Vaninbroukx | 229 | 386 | 219 | 33 | 694 | |
| J.P. Laissy | 283 | 192 | 124 | 43 | 721 | |
| J Rösch | 224 | 302 | 80 | 32 | 668 | |
| F. Fobbe | 219 | 120 | 71 | 38 | 547 | |
| Waleska M. Pabon‐Ramos | 363 | 159 | 84 | 47 | 626 | |
| Joseph McDevitt | 271 | 174 | 47 | 32 | 570 | |
| Se Hwan Kwon | 453 | 172 | 52 | 60 | 693 | |
| Ceyla Başaran | 198 | 127 | 75 | 30 | 586 |
All Works
Login with ORCID to disown or claim papers
Loading papers...